Global efforts to reduce infectious disease rates must have a greater focus on older children and adolescents after a shift in disease burden onto this demographic, according to a new study.
Gero Raises $6M for Physics-Powered GenAI Biotech
What You Should Know: Gero, a biotechnology company focused on aging and chronic diseases, has closed $6M in a Series A extension round. This funding